Ambrisentan Tablet, Film Coated
Product Images NDC 70710-1179

This appears to be a chart of interacting drugs with Ambrisentan, a medication used to treat pulmonary arterial hypertension. The chart includes 10 other drugs, such as Cyclosporine and Mycophenolate Mofetil, with recommendations on whether or not to adjust the dose of Ambrisentan when used in combination with each drug. The column "PR" is not defined and the numbers across the bottom appear to indicate a "fold change" relative to Ambrisentan alone.*

This is a list of drugs and their interactions with other drugs. It also includes PK information such as Cmax and AUC. There are no recommended dose adjustments for any of the drugs listed.*

This appears to be a graphical representation of clinical trial data for the drugs Ambrisentan and Placebo, in two different trials (ARIES-1 and ARIES-2), plotted against time in weeks. The y-axis represents the percentage of patients who remained in the study at that time point, while the x-axis shows the time elapsed in weeks. The number of patients at risk at each time point is also included.*

This is a medication label for Ambrisentan tablets, which should not be split, crushed, or chewed. The usual dosage should be determined by the prescribing information. The tablets should be stored at a temperature between 20°C to 25°C, with excursions permitted up to 15°C to 30°C. The medication should be dispensed in the original container, which should be kept tightly closed. The label also includes the medication's NDC number, manufacturer (Cadila Healthcare Ltd in Ahmedabad, India), and an instruction to the pharmacist to dispense the medication with the accompanying information.*

This is a description of medication named Ambrisentan. The tablets come in a pack of 30 and are dispensed under prescription only. Each tablet contains 10mg of the Ambrisentan. The usual dosage information is provided in the accompanying prescription information. The tablets are film-coated and must not be split, crushed, or chewed. They should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F). The medication should be kept in the original container, and the accompanying medication guide should be provided to each patient. The manufacturer of the medication is Cadla Healthcare Ltd Ahmedabed, India, and it is distributed by Zydus Pharmaceuticals (USA) Inc. in Penringlon, NJ 08534.*